Compare iShares MSCI ACWI ETF (ACWI) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI ACWI ETF vs DexCom, Inc. — how do they compare? iShares MSCI ACWI ETF trades at $161.56, while DexCom, Inc. trades at $90.9 (market cap $33.79B). Which is the better fit depends on your goals.
| ACWI | DXCM | |
|---|---|---|
52-Week High | $161.44 | $89.53 |
52-Week Low | $132.04 | $54.84 |
Market Cap | — | $33.79B |
Sector | — | Health |
Enterprise Value | — | $33.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACWI trades at $161.64, up 0.34% today, with a bullish technical signal from moving averages and strong trend momentum indicated by the ADX. The ETF benefits from robust global earnings growth and significant institutional interest, as highlighted by recent news of major holdings. A forward P/E of 15.5x suggests reasonable valuation amid the rally.
The outlook remains positive, driven by sustained EPS growth and investor inflows into global equity ETFs, particularly in technology. Key risks include potential overbought conditions signaled by RSI and broader market volatility. Analyst sentiment is bullish, supporting further upside potential.
DXCM trades at $91.00, up 3.82% today and near its 52-week high, with bullish technical signals from moving averages and strong fundamentals. Recent Q2 2026 earnings beat expectations with EPS of $0.70 versus $0.61 expected, driven by 13% revenue growth and margin expansion. The company raised full-year 2026 guidance, reflecting robust demand for continuous glucose monitors.
The outlook is positive due to sustained revenue growth, profitability improvements, and analyst consensus favoring buys. Risks include competitive pressures and potential regulatory scrutiny, but institutional ownership trends and earnings momentum support a constructive view for investors seeking exposure to medical technology.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI ACWI ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries.
Read more on ACWI →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
